Neurological Disorders & Stroke

About Conference

Sessions and Tracks

Track 1 : Neurodegenerative Diseases: Updates on Alzheimer's, Parkinson's

This Neurodegenerative Diseases : Updates on Alzeimer's, Parkinsons provides a focused update on the latest advancements in the understanding, diagnosis, and treatment of Alzheimer's and Parkinson's diseases. Experts in the field will present cutting-edge research findings, clinical insights, and emerging therapies, offering attendees a comprehensive overview of the current state of these neurodegenerative disorders. This track provides a focused update on the latest advancements in the understanding, diagnosis, and treatment of Alzheimer's and Parkinson's diseases. Experts in the field will present cutting-edge research findings, clinical insights, and emerging therapies, offering attendees a comprehensive overview of the current state of these neurodegenerative disorders. They will discuss innovative therapeutic strategies, including disease-modifying therapies, gene therapies, stem cell-based approaches, and targeted drug interventions. 

Relevant Socities :  American Stroke Association | National Stroke Association | American Academy of Neurology | American Society of Neurorehabilitation | American College of Emergency Physicians | American Stroke Foundation | National Stroke Foundation

Track 2 : Stroke and Cerebrovascular Diseases: Advances in Diagnosis and Treatment

This Stroke and Cerebrovascular Diseases: Advances in Diagnosis and Treatment will highlight the latest advancements in the diagnosis and treatment of cerebrovascular diseases, including ischemic and hemorrhagic strokes.During a stroke, things move quickly once you get to the hospital. Your emergency team works to learn what type of stroke you're having. You'll likely have a CT scan or other imaging test soon after arrival. Healthcare professionals also need to rule out other possible causes of your symptoms, such as a brain tumor or a drug reaction. Emergency treatment depends on whether you're having an ischemic or hemorrhagic stroke. During an ischemic stroke, blood vessels in the brain are blocked or narrowed. During a hemorrhagic stroke, there's bleeding into the brain. An IV medicine that can break up a clot has to be given within 4.5 hours from when symptoms began. The sooner the medicine is given, the better. Quick treatment improves your chances of survival and may reduce complications.

Relevant Socities :  Canada Stroke and Neurology Associations | Canadian Stroke Consortium | Canadian Neurological Sciences Federation | Canadian Neurological Society | Canadian Association of Neuroscience Nurses | Canadian Stroke Nurses Education Network.

Track 3 : Neuroimaging Techniques: Latest Developments in Imaging Technologies

This Neuroimaging Techniques: Latest Developments in Imaging Technologies  will focus on the latest advancements in neuroimaging techniques, highlighting innovations in imaging technologies that are transforming the field of neuroscience.Cranial X-ray examination, computed tomography (CT), and ordinary magnetic resonance imaging (MRI) are traditional neuroimaging techniques. Skull X-ray examination is of great diagnostic value for abnormal changes in bone tissue in the head. In particular, this technique can be used to evaluate the development and aging of the skull and ascertain the presence of bone hyperplasia, osteoporosis, degeneration, corrosion, damage, and calcification (Kim et al., 2020). However, abnormal changes in brain tissue and other central nervous tissue cannot be distinguished via head X-ray examination, and so this technique is of little value in the diagnosis of AD. 

Relevant Socities :  German Stroke Society | German Society for Neurology | German Stroke Foundation | German Society for Neurocritical Care | German Society for Neurorehabilitation |  German Society for Emergency Medicine.

Track 4 : Neurocardiology: Study of the interaction between the brain and the cardiovascular system

This Neurocardiology: Study of the interaction between the brain and the cardiovascular system. will highlight the  Neurocardiology is a field of study that focuses on the interactions between the brain and the cardiovascular system. It explores how the brain influences heart function and vice versa, as well as the impact of this interaction on overall health. Research in neurocardiology examines the neural pathways and mechanisms that regulate heart rate, blood pressure, and other cardiovascular functions controlled by the autonomic nervous system. Understanding the complex relationship between the brain and the heart is essential for developing treatments for conditions such as hypertension, heart failure, and arrhythmias, where dysfunction in this interaction may play a role.

Relevant Socities :  Stroke Foundation Australia | Neurological Society of Australia | Australian and New Zealand Association of Neurologists |  Australian Stroke Coalition | Australian Physiotherapy Association - Neurology Group | Australian Neuroscience Society.

Track 5 : Neurogenetics and Neurological Disorders: From Genes to Clinical Practice

The field of neurogenetics has significantly advanced our understanding of the genetic factors underlying neurological disorders. This session focuses on the intricate relationship between genetics and neurological disorders, exploring the journey from genes to clinical practice.During this session, experts in neurogenetics will present the latest research findings on the genetic basis of neurological disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and epilepsy. They will discuss the identification of disease-causing genes, genetic risk factors, and the complex interplay between genetics and environmental factors. Discussions will revolve around the translation of genetic discoveries into clinical practice. Experts will share insights on the diagnostic applications of genetic testing, genetic counseling, and the integration of genetic information into personalized treatment strategies. The session will also cover the advancements in genomic technologies, such as next-generation sequencing and whole-genome sequencing, which have revolutionized the field of neurogenetics and facilitated the identification of rare genetic variants.

Relevant Socities :  American Stroke Association | National Stroke Association | American Academy of Neurology | American Society of Neurorehabilitation | American College of Emergency Physicians | American Stroke Foundation | National Stroke Foundation.

Track  6 : Cognitive Impairment in Neurological Disorders: From Assessment to Intervention
 

Cognitive impairment is a common and often debilitating consequence of various neurological disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and stroke. This session focuses on the comprehensive assessment and intervention strategies for cognitive impairment in neurological disorders.During this session, experts will discuss the latest advancements in cognitive assessment tools, neuropsychological testing, and neuroimaging techniques used to evaluate cognitive functioning in patients with neurological disorders. Presentations will cover the importance of early and accurate diagnosis, as well as the identification of specific cognitive domains affected by different disorders. The session will also explore evidence-based interventions and rehabilitation strategies for cognitive impairment. Experts will highlight the effectiveness of cognitive training, cognitive rehabilitation programs, pharmacological treatments, and non-pharmacological interventions in improving cognitive function, promoting independence, and enhancing quality of life for individuals with neurological disorders.

Relevant Socities :  Canada Stroke and Neurology Associations | Canadian Stroke Consortium | Canadian Neurological Sciences Federation | Canadian Neurological Society | Canadian Association of Neuroscience Nurses | Canadian Stroke Nurses Education Network.

Track 7 : Neurophotonics: Harnessing Light to Explore the Nervous System

The Neurophotonics : Harnessing Light to Explore the Nervous Systerm .Neurophotonics is a rapidly evolving field that utilizes light-based technologies to study the structure and function of the nervous system at various scales, from individual neurons to large-scale brain networks. This track will highlight recent advancements in neurophotonics and its applications in neuroscience research and clinical practice. Topics covered may include: Optical Imaging Techniques is a overview of advanced optical imaging techniques, such as two-photon microscopy, light-sheet microscopy, and super-resolution imaging, for studying neural structure and function. Functional Neuroimaging is about the updates on functional neuroimaging techniques, such as functional near-infrared spectroscopy (fNIRS) and optoacoustic imaging, for mapping brain activity and connectivity

Relevant Socities :  German Stroke Society | German Society for Neurology | German Stroke Foundation | German Society for Neurocritical Care | German Society for Neurorehabilitation |  German Society for Emergency Medicine.

Track 8 : Neurological Complications of COVID-19: Understanding the Impact and Management
 

The COVID-19 pandemic has brought attention to the various ways the virus affects the body, including its impact on the nervous system. This session focuses on understanding the neurological complications associated with COVID-19 and exploring their management strategies.During this session, experts will present the latest research findings on the neurological manifestations of COVID-19. They will discuss the diverse range of neurological complications observed, such as encephalopathy, stroke, Guillain-Barré syndrome, and anosmia. Presentations will delve into the underlying mechanisms, including direct viral invasion, immune-mediated responses, and hypercoagulability. Discussions will revolve around diagnostic approaches and management strategies for neurological complications in COVID-19 patients. Experts will highlight the importance of early recognition, comprehensive neurological assessment, and multidisciplinary care in optimizing patient outcomes. The session will also address the long-term effects and potential neurorehabilitation needs of COVID-19 survivors.

Relevant Socities :  Stroke Foundation Australia | Neurological Society of Australia | Australian and New Zealand Association of Neurologists |  Australian Stroke Coalition | Australian Physiotherapy Association - Neurology Group | Australian Neuroscience Society.

Track  9 : Ethical Issues in Neurological Research and Practice: Balancing Innovation and Patient Rights

Neurological research and practice are constantly evolving, introducing new interventions, therapies, and technologies. However, alongside these advancements, ethical considerations play a crucial role in ensuring the well-being and rights of patients. This session focuses on the ethical issues that arise in neurological research and practice, emphasizing the need to strike a balance between innovation and patient rights.During this session, experts will discuss a range of ethical issues encountered in neurological research and practice. They will explore topics such as informed consent, privacy and data protection, equity in access to care, and the responsible use of emerging technologies. Presentations will highlight the ethical considerations specific to neurological disorders, including decision-making capacity, end-of-life care, and the use of neuroenhancement techniques. Experts will discuss the importance of promoting patient autonomy, beneficence, and justice in neurological research and clinical care

Relevant Socities :  American Stroke Association | National Stroke Association | American Academy of Neurology | American Society of Neurorehabilitation | American College of Emergency Physicians | American Stroke Foundation | National Stroke Foundation.

Track 10 : Neuropharmacology: Exploring Drug Effects on the Nervous System

Neuropharmacology is a field of study that focuses on understanding how drugs affect the nervous system, including the brain, spinal cord, and peripheral nerves. This track will explore the latest research and developments in neuropharmacology, highlighting new insights into the mechanisms of action of drugs used to treat neurological disorders. Drug Developments a updates on the development of novel drugs for the treatment of neurological disorders, including Alzheimer's disease, Parkinson's disease, and epilepsy. Neurotransmitter Systems Discussion on the role of neurotransmitters, such as dopamine, serotonin, and glutamate, in mediating drug effects on the nervous system. Neuropharmacology of Addiction Study of the neurobiological mechanisms underlying drug addiction and potential pharmacological interventions. Drug-Drug Interactions Effects of drug-drug interactions on the efficacy and safety of neuropharmacological treatments.

Relevant Socities :  Canada Stroke and Neurology Associations | Canadian Stroke Consortium | Canadian Neurological Sciences Federation | Canadian Neurological Society | Canadian Association of Neuroscience Nurses | Canadian Stroke Nurses Education Network

Track 11 : Neurovirology: Understanding Viral Infections of the Nervous System

Neurovirology is a specialized field that focuses on the study of viruses that infect the nervous system. This track will explore the latest research and developments in neurobiology, highlighting new insights into the mechanisms of viral infections of the nervous system and their impact on neurological function. Immune Response role of the immune response in controlling viral infections of the nervous system and its contribution to neurological damage. Viral-Induced Neurological Disorders. Viral Diagnostics Advances in diagnostic techniques for detecting viral infections of the nervous system, including molecular and imaging methods.

Relevant Socities :  Stroke Foundation Australia | Neurological Society of Australia | Australian and New Zealand Association of Neurologists |  Australian Stroke Coalition | Australian Physiotherapy Association - Neurology Group | Australian Neuroscience Society.

 Track 12 : Neuroendocrinology: Exploring the Brain-Endocrine System Interaction

Neuroendocrinology is a field of study that focuses on the interactions between the nervous system and the endocrine system. This track will explore the latest research and developments in neuroendocrinology, highlighting new insights into the mechanisms by which the brain regulates hormonal activity and vice versa. Hypothalamic-Pituitary Axis the role of the hypothalamus and pituitary gland in regulating hormone secretion and their impact on physiological processes. Neurotransmitters and Hormones: neurotransmitters and hormones in mediating the communication between the brain and the endocrine system.Stress and Hormonal Response Study of the neuroendocrine response to stress and its impact on health and disease. Neuroendocrinology of Reproduction Exploration of the neuroendocrine mechanisms regulating reproductive function, including puberty, menstruation, and fertility.Neuroendocrine Disorders diagnosis and management of neuroendocrine disorders, such as hypothalamic-pituitary tumors and adrenal insufficiency.

Relevant Socities :  German Stroke Society | German Society for Neurology | German Stroke Foundation | German Society for Neurocritical Care | German Society for Neurorehabilitation |  German Society for Emergency Medicine.
 

Track 13 : Neurosurgery: Advancements in Surgical Techniques for Neurological Disorders

Neurosurgery is a specialized field that focuses on the surgical treatment of neurological disorders affecting the brain, spinal cord, and peripheral nerves.Minimally Invasive Neurosurgery minimally invasive techniques for brain and spinal surgery, including endoscopic and robotic-assisted approaches.Neuro-Oncology Surgery Advances in surgical techniques for the treatment of brain tumors, including intraoperative imaging and tumor resection.Functional Neurosurgery surgical treatments for movement disorders, epilepsy, and psychiatric conditions, including deep brain stimulation and ablative procedures.Spinal Surgery spinal fusion techniques, disc replacement surgery, and minimally invasive spinal decompression procedures.Vascular Neurosurgery for the treatment of cerebrovascular disorders, including aneurysms, arteriovenous malformations, and stroke.Pediatric Neurosurgery surgical treatments for neurological disorders in children, including hydrocephalus, spina bifida, and brain tumors.

Relevant Socities :  American Stroke Association | National Stroke Association | American Academy of Neurology | American Society of Neurorehabilitation | American College of Emergency Physicians | American Stroke Foundation | National Stroke Foundation.

Market Analysis

The 14th International Conference on Neurology and Stroke Disorder The global market for neurology and stroke disorders is expected to witness significant growth from 2020 to 2026, driven by several factors such as increasing prevalence of neurological disorders, technological advancements in diagnosis and treatment, and growing geriatric population. Here is an analysis of the market during this period.

North America : The largest market for neurology and stroke disorders, driven by a high prevalence of these disorders, advanced healthcare infrastructure, and presence of key market players.

Europe: The second-largest market, driven by increasing healthcare expenditure and rising awareness about neurological disorders.

Asia-Pacific: Expected to witness significant growth, attributed to the increasing geriatric population, rising prevalence of neurological disorders, and improving healthcare infrastructure.Rest of the World: Including Latin America and the Middle East, is also experiencing growth, driven by improving healthcare facilities and rising awareness.

Increasing Prevalence: The rising prevalence of neurological disorders, such as Alzheimer's disease, Parkinson's disease, and stroke, is a key driver of market growth. Advances in diagnostics, imaging, and treatment options are driving market growth. The aging population is more prone to neurological disorders, leading to increased demand for treatment options. Increasing healthcare expenditure and government initiatives to improve neurological care are driving market growth. High Cost of Treatment The high cost of treatment for neurological disorders and stroke is a significant challenge, particularly in developing countries.Lack of Awareness Limited awareness about neurological disorders and their treatment options among patients and healthcare providers is a barrier to market growth. Regulatory Challenges Stringent regulatory requirements for the approval of new treatments pose a challenge for market players.

Overall, the global market for neurology and stroke disorders is expected to witness significant growth from 2020 to 2026, driven by increasing prevalence and advancements in treatment options. Addressing challenges such as high treatment costs and lack of awareness will be crucial for market players to capitalize on this growth opportunity.

Past Conference

The 9th International Conference on Neurological Disorders and Stroke is a highly anticipated event that will take place on May 16-17,2024, in the vibrant city of Rome,Italy. This conference serves as a global platform for leading neurologists, neuroscientists, researchers, and healthcare professionals to exchange knowledge, share ground breaking research, and discuss advancements in the field of neurology.

With a focus on neurological disorders and stroke, this conference aims to provide a comprehensive overview of the latest research, innovations, and treatment modalities. Attendees will have the opportunity to engage in stimulating discussions, attend insightful keynote presentations, and participate in interactive workshops and poster sessions. The conference program will cover a wide range of topics, including neurodegenerative diseases, stroke prevention and rehabilitation,